Skip to content

What marks out HIV controllers from others?

Michaela Müller-Trutwin at the HIV Cure and Cancer Forum, IAS 2017. Photo by Marcus Rose/IAS

Why curing HIV may be like curing cancer – and may be as difficult

Monsef Benkirane at the HIV Cure and Cancer Forum, IAS 2017. Photo by Marcus Rose/IAS

Can we achieve a complete HIV cure in more patients?

Michael Louella at the HIV Cure and Cancer Forum, IAS 2017. Photo by Marcus Rose/IAS

VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment

Trevor Crowell at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

South African child has controlled HIV off treatment for 8.5 years

South African child has controlled HIV off treatment for 8.5 years

Research helps explain how vedolizumab antibody therapy leads to sustained viral remission

Researchers report case of bone marrow transplant patient off ART for 288 days without HIV rebound

Spanish vaccine induces viral control off ART in nearly 40% of recipients

Spanish vaccine induces viral control off ART in nearly 40% of recipients

Infants treated within days of birth can clear HIV reservoir rapidly

Louise Kuhn at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com